Sravan K. Emany - 31 Dec 2024 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Signature
By: /s/ Christine Bellon, Attorney-in-fact
Issuer symbol
BEAM
Transactions as of
31 Dec 2024
Transactions value $
$0
Form type
4
Filing time
02 Jan 2025, 20:04:15 UTC
Previous filing
19 Dec 2024
Next filing
09 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BEAM Common Stock Award $0 +80K $0.00 80K 31 Dec 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Award $0 +160K $0.00 160K 31 Dec 2024 Common Stock 160K $24.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan (the "Plan"). Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSU vests in four substantially equal installments on each of the first four anniversaries of December 31, 2024, subject to the Reporting Person's continued service with BEAM through each vesting date.
F2 This stock option vests as to 25% on the first anniversary of the vesting commencement date, December 31, 2024, and at a rate of 2.78% each month thereafter until the option is fully vested.